These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
781 related articles for article (PubMed ID: 27215797)
41. Hepatitis E virus seroprevalence among schistosomiasis patients in Northeastern Brazil. Passos-Castilho AM; de Sena A; Domingues AL; Lopes-Neto EP; Medeiros TB; Granato CF; Ferraz ML Braz J Infect Dis; 2016; 20(3):262-6. PubMed ID: 27020708 [TBL] [Abstract][Full Text] [Related]
42. [Hepatitis A and hepatitis E seroprevalence in adults in the Ankara area]. Cesur S; Akin K; Doğaroğlu I; Birengel S; Balik I Mikrobiyol Bul; 2002 Jan; 36(1):79-83. PubMed ID: 12476770 [TBL] [Abstract][Full Text] [Related]
43. Hepatitis E seroprevalence in the United States: Results for immunoglobulins IGG and IGM. Cangin C; Focht B; Harris R; Strunk JA J Med Virol; 2019 Jan; 91(1):124-131. PubMed ID: 30168589 [TBL] [Abstract][Full Text] [Related]
44. Incidence of Hepatitis E Infection in American Patients With Suspected Drug-Induced Liver Injury Is Low and Declining: The DILIN Prospective Study. Fontana RJ; Engle RE; Hayashi PH; Gu J; Kleiner DE; Nguyen H; Barnhart H; Hoofnagle JH; Farci P Am J Gastroenterol; 2022 Sep; 117(9):1462-1470. PubMed ID: 35973149 [TBL] [Abstract][Full Text] [Related]
45. Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011. Mansuy JM; Saune K; Rech H; Abravanel F; Mengelle C; L Homme S; Destruel F; Kamar N; Izopet J Euro Surveill; 2015 May; 20(19):27-34. PubMed ID: 25990359 [TBL] [Abstract][Full Text] [Related]
46. Significance of serum IgA in patients with acute hepatitis E virus infection. Tian DY; Chen Y; Xia NS World J Gastroenterol; 2006 Jun; 12(24):3919-23. PubMed ID: 16804983 [TBL] [Abstract][Full Text] [Related]
47. Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients. Shalimar ; Kedia S; Gunjan D; Sonika U; Mahapatra SJ; Nayak B; Kaur H; Acharya SK Dig Dis Sci; 2017 Apr; 62(4):1058-1066. PubMed ID: 28130708 [TBL] [Abstract][Full Text] [Related]
48. Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years. Gu G; Huang H; Zhang L; Bi Y; Hu Y; Zhou YH BMC Infect Dis; 2015 Dec; 15():560. PubMed ID: 26653888 [TBL] [Abstract][Full Text] [Related]
49. A Special Risk Group for Hepatitis E Infection: The First Record of North Cyprus. Süer K; Güvenir M; Aykaç A Pol J Microbiol; 2018; 67(4):525-528. PubMed ID: 30550239 [TBL] [Abstract][Full Text] [Related]
50. Identification of hepatitis E virus subtype 4f in blood donors in Shanghai, China. Chen X; Gong P; Wagner AL; Li Y; Wang G; Lu Y Virus Res; 2019 May; 265():30-33. PubMed ID: 30836112 [TBL] [Abstract][Full Text] [Related]
51. [A preliminary study on hepatitis E virus antibody IgG and IgM for the diagnosis of acute hepatitis E]. Li K; Zhuang H; Zhu W; Ruan B; Jiang J; Li S; Zhai Q; Yao Z; Tang R; Chen Y Zhonghua Nei Ke Za Zhi; 1999 Nov; 38(11):733-6. PubMed ID: 11798711 [TBL] [Abstract][Full Text] [Related]
52. Seroprevalence and risk factors of hepatitis E virus infection among children in China. Meng QF; You HL; Wang WL; Zhou N; Dong W; Cong W J Med Virol; 2015 Sep; 87(9):1573-7. PubMed ID: 25940435 [TBL] [Abstract][Full Text] [Related]
53. Hepatitis E virus seroprevalence in acute viral hepatitis in a developed country confirmed by a supplemental assay. Quiroga JA; Cotonat T; Castillo I; Carreño V J Med Virol; 1996 Sep; 50(1):16-9. PubMed ID: 8890035 [TBL] [Abstract][Full Text] [Related]
54. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. Rossi-Tamisier M; Moal V; Gerolami R; Colson P J Clin Virol; 2013 Jan; 56(1):62-4. PubMed ID: 23089569 [TBL] [Abstract][Full Text] [Related]
55. Diagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort Study. Norder H; Karlsson M; Mellgren Å; Konar J; Sandberg E; Lasson A; Castedal M; Magnius L; Lagging M J Clin Microbiol; 2016 Mar; 54(3):549-55. PubMed ID: 26659210 [TBL] [Abstract][Full Text] [Related]
56. Hepatitis E virus seroprevalence in Polish soldiers serving in harsh environmental conditions. Korzeniewski K; Osińska J; Korsak J; Konior M Int Marit Health; 2018; 69(2):137-141. PubMed ID: 29939391 [TBL] [Abstract][Full Text] [Related]
57. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. Wenzel JJ; Preiss J; Schemmerer M; Huber B; Jilg W J Infect Dis; 2013 Feb; 207(3):497-500. PubMed ID: 23148290 [TBL] [Abstract][Full Text] [Related]
58. Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands. van Gerven NM; van der Eijk AA; Pas SD; Zaaijer HL; de Boer YS; Witte BI; van Nieuwkerk CM; Mulder CJ; Bouma G; de Man RA; J Gastrointestin Liver Dis; 2016 Mar; 25(1):9-13. PubMed ID: 27014749 [TBL] [Abstract][Full Text] [Related]
59. High seroprevalence against hepatitis E virus in patients with chronic hepatitis C virus infection. Mellgren Å; Karlsson M; Karlsson M; Lagging M; Wejstål R; Norder H J Clin Virol; 2017 Mar; 88():39-45. PubMed ID: 28160727 [TBL] [Abstract][Full Text] [Related]
60. Anti-hepatitis E virus antibody prevalence in French expatriate workers. Vernier M; Rossi-Tamisier M; Richet H; Brouqui P; Parola P; Bouamri Y; Colson P; Gautret P Int J Infect Dis; 2013 Nov; 17(11):e1082-4. PubMed ID: 23953700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]